Skip to main content
. 2020 Apr 7;2020:6495036. doi: 10.1155/2020/6495036

Figure 1.

Figure 1

Bar graph showing the rate of major clinical events in clinical trials comparing 12-month dual antiplatelet strategy (DAPT) vs. a shorter strategy followed by ASA alone.